THIRD ANNUAL INTERNATIONAL MEETING

CONTRIBUTED ORIGINAL RESEARCH ABSTRACTS

The contributed original research abstracts are published in:
VALUE IN HEALTH - The Journal of the International Society for Pharmacoeconomics and Outcomes Research Vol. 1, No. 1

To order a copy of this issue, mail your request to:
Blackwell Science Inc.
Journal Fulfillment Dept.
Commerce Place, 350 Main Street
Malden, MA 02148-5018

or: Call 1-888-661-5800 or 781-388-8250 outside the US or: Fax: 781-388-8270

	ABSTRACT INDEX
	CM WORKSHOPS: COSTING METHODOLOGY ISSUES
CM1	ESTIMATING THE COSTS AND OUTCOMES FOR DIFFERENT DISEASE MANAGEMENT STRATEGIES: A CASE STUDY OF CYTOMEGALOVIRUS INFECTION AND DISEASE
CM2	CLINICAL INTERVENTION ASSESSMENT: IMPLEMENTATION OF DEFAULT VALUES FOR EXPEDITING THE CALCULATION OF COST SAVINGS AND COST AVOIDANCES
CM3	MULTIVARIABLE METHODS FOR MEASURING TREATMENT COSTS IN RANDOMIZED TRIALS A
CM4	USE OF UB-92S AND MEDICARE COST REPORTS IN LARGE, MULTI-CENTER RANDOMIZED TRIAL: THE PURSUIT EXPERIENCE
CM5	DISCOUNTING HEALTH BENEFITS IN PHARMACOECONOMIC ANALYSES: IS IT JUSTIFIED?
CM6	THE USE OF PATIENT SELF-REPORTS TO COLLECT HEALTH CARE RESOURCE UTILIZATION DAT
	DA WORKSHOPS: DATA ANALYSIS
DA1	USING MEDICATION HISTORY TO MEASURE INDICATION BIAS
DA2	THE ROLE OF PATIENT REGISTRIES IN DISEASE MANAGEMENT AND OUTCOMES RESEARCH
DA3	USING COMMUNITY PHARMACIES TO CONDUCT OUTCOMES RESEARCH
DA4	CONSTRUCTION OF A VALIDATED, NORMALIZED, GRANULAR ADMINISTRATIVE DATABASE AND ITS USE IN CLINICAL OUTCOMES IMPROVEMENT, CLINICAL RESEARCH AND PHARMACOECONOMIC RESEARCH
DA5	DISEASE STATE MANAGEMENT TRACKER: IMPLEMENTING, TRACKING, AND EVALUATING CLINICAL PATHWAYS AND OUTCOMES
DA6	STRATEGIES FOR FORMULARY COMPARISONS IN THE MEDICAID MANAGED CARE ERA
DA7	PROSPECTIVE, NATURALISTIC OUTCOMES MEASUREMENT: THE SCHIZOPHRENIA CARE AND ASSESSMENT PROGRAM (SCAP)
DA8	EVALUATING HEALTH OUTCOMES AND PHARMACOECONOMIC LITERATURE
	DM WORKSHOPS: DECISION METHODS
DM1	INTERPRETING AND USING COST EFFECTIVENESS RESULTS
DM2	DISSEMINATION OF PHARMACOECONOMIC RESULTS TO MANAGED CARE ORGANIZATIONS
DM3	OUTCOMES RESEARCH IN MEDICATION USE: HCFA¹S HEALTH CARE QUALITY IMPROVEMENT PROGRAM
	MM WORKSHOPS: MODELING METHODS
MM1	MONTE CARLO SIMULATION IN HEALTH CARE MODELS
MM2	DESIGNING COMPUTER MODELS TO CONVEY COST-EFFECTIVENESS ANALYSES RESULTS
MM3	DEVELOPMENT OF DRUG USE PERFORMANCE MODELS AS MEASURES OF PATIENT CARE
MM4	RECONCILING DECISION MODELS WITH THE REAL WORLD: THE COST-EFFECTIVENESS OF ERYTHROPOIETIN FOR ESRD-RELATED ANEMIA
MM5	COMPARING COMPUTERIZED OPTIONS IN PHARMACOECONOMICS: SPREADSHEETS, DECISION TREES AND EDUCATIONAL TOOLS. AN OPEN WORKSHOP FOR DEMONSTRATING SOFTWARE
MM6	DECISION ANALYSIS: WHAT IS ITS UTILITY FOR PHARMACOECONOMIC ANALYSIS?
MM7	ISSUES IN DEVELOPING ECONOMIC MODELS FOR MANAGED CARE: THE CASE OF OSTEOPOROSIS PREVENTION
	UT WORKSHOPS: UTILITIES METHODS
UT1	TRADE-OFF PREFERENCES FOR PHARMACEUTICAL DEVELOPMENT, MARKETING, AND OUTCOMES EVALUATION
UT2	PRACTICAL APPLICATIONS OF THE HEALTH UTILITIES INDEX
UT3	THE EuroQoL EQ-5D : AN OUTCOME MEASURE FOR USE IN CLINICAL AND ECONOMIC EVALUATION